Wenqi Zhou

No. 181 Hanyu Road
Tanjiagang, 400030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

The prognostic value of peripheral blood inflammatory markers in patients with HER2-positive metastatic breast cancer treated with pyrotinib.

The prognostic value of peripheral blood inflammatory markers in patients with HER2-positive metastatic breast cancer treated with pyrotinib.

Journal: Frontiers in oncology

Published: February 16, 2026

Pathological response and metabolites' prognostic role in HER2-positive breast cancer treated with neoadjuvant pyrotinib, trastuzumab, nab-paclitaxel, and carboplatin: a single-arm phase II trial.

Pathological response and metabolites' prognostic role in HER2-positive breast cancer treated with neoadjuvant pyrotinib, trastuzumab, nab-paclitaxel, and carboplatin: a single-arm phase II trial.

Journal: Breast cancer research : BCR

Published: January 29, 2025

The role of locoregional surgery in de novo stage IV breast cancer: A meta-analysis of randomized controlled trials.

The role of locoregional surgery in de novo stage IV breast cancer: A meta-analysis of randomized controlled trials.

Journal: Cancer treatment reviews

Published: February 13, 2024

Thoracic aorta injury detected by 4D flow MRI predicts subsequent main adverse cardiovascular events in breast cancer patients receiving anthracyclines: A longitudinal study.

Thoracic aorta injury detected by 4D flow MRI predicts subsequent main adverse cardiovascular events in breast cancer patients receiving anthracyclines: A longitudinal study.

Journal: Magnetic resonance imaging

Published: January 20, 2024

A Single-Arm Phase II Clinical Trial of Fulvestrant Combined with Neoadjuvant Chemotherapy of ER+/HER2- Locally Advanced Breast Cancer: Integrated Analysis of 18F-FES PET-CT and Metabolites with Treatment Response.

A Single-Arm Phase II Clinical Trial of Fulvestrant Combined with Neoadjuvant Chemotherapy of ER+/HER2- Locally Advanced Breast Cancer: Integrated Analysis of 18F-FES PET-CT and Metabolites with Treatment Response.

Journal: Cancer research and treatment

Published: November 24, 2023

Quantification of Hepatic Steatosis on Dual-Energy CT in Comparison With MRI mDIXON-Quant Sequence in Breast Cancer.

Quantification of Hepatic Steatosis on Dual-Energy CT in Comparison With MRI mDIXON-Quant Sequence in Breast Cancer.

Journal: Journal of computer assisted tomography

Published: August 09, 2023

Metabolomics assisted by transcriptomics analysis to reveal metabolic characteristics and potential biomarkers associated with treatment response of neoadjuvant therapy with TCbHP regimen in HER2 + breast cancer.

Metabolomics assisted by transcriptomics analysis to reveal metabolic characteristics and potential biomarkers associated with treatment response of neoadjuvant therapy with TCbHP regimen in HER2 + breast cancer.

Journal: Breast cancer research : BCR

Published: June 02, 2023

Additional adjuvant capecitabine in early breast cancer patients: a meta-analysis of randomized controlled trials.

Additional adjuvant capecitabine in early breast cancer patients: a meta-analysis of randomized controlled trials.

Journal: Future oncology (London, England)

Published: October 25, 2021

Survival benefit of pure dose-dense chemotherapy in breast cancer: a meta-analysis of randomized controlled trials.

Survival benefit of pure dose-dense chemotherapy in breast cancer: a meta-analysis of randomized controlled trials.

Journal: World journal of surgical oncology

Published: February 07, 2018

Showing 1-9 of 9

Last Updated: 09/26/2026